We are live on
!
Find out more
GCM
Ghisallo Capital Management Portfolio holdings
AUM
$5.1B
1-Year Est. Return
39.13%
This Fund
S&P 500
This Quarter
Est. Return
+15.09%
1 Year Est. Return
+39.13%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.89%
10 Year Est. Return
–
AUM
$5.1B
AUM Growth
+$1.47B
(+40%)
Cap. Flow
+$410M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
42.59%
Holding
458
New
148
Increased
12
Reduced
51
Closed
123
Avg Time Held
1.3
quarters
Top 10 Avg Time Held
0.3
quarters
Top 20 Avg Time Held
0.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$965M |
| 2 |
Digital Realty Trust
DLR
|
+$229M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$144M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$143M |
| 5 |
Super Micro Computer
SMCI
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$102M |
| 2 |
NVIDIA
NVDA
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$92.5M |
| 4 |
GlobalFoundries
GFS
|
+$80.1M |
| 5 |
Medline Inc
MDLN
|
+$62.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 29.61% |
| 2 | Miscellaneous | 19.42% |
| 3 | Communication Services | 10.49% |
| 4 | Technology | 8.11% |
| 5 | Healthcare | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Beta Technologies Inc
BETA
$4.21B
| $1.68M | 0.03% |
100,000
-150,000
| -60% | -$2.5M |
2025 Q4
2 quarters
|
|
227
Mobia Medical
MOBI
$281M
| $1.68M | 0.03% |
+125,000
| New | +$1.62M |
2026 Q2
0 quarters
|
|
228
Praxis Precision Medicines
PRAX
$6.81B
| $1.67M | 0.03% |
5,000
| – | – |
2026 Q1
1 quarter
|
|
229
Kailera Therapeutics
KLRA
$1.41B
| $1.65M | 0.03% |
+75,000
| New | +$1.65M |
2026 Q2
0 quarters
|
|
230
Voyager Technologies
VOYG
$1.62B
| $1.61M | 0.03% |
50,000
-25,000
| -33% | -$865K |
2025 Q2
4 quarters
|
|
231
Willow Lane Acquisition Corp II
WLII
$206M
| $1.53M | 0.03% |
+150,000
| New | +$1.51M |
2026 Q2
0 quarters
|
|
232
Fortress Value Acquisition Corp V
FVAV
$369M
| $1.52M | 0.03% |
150,000
| – | – |
2026 Q1
1 quarter
|
|
233
Iron Dome Acquisition I Corp Units
IDACU
| $1.51M | 0.03% |
+150,000
| New | +$1.51M |
2026 Q2
0 quarters
|
|
234
Keystone Acquisition Corp Unit
KEYYU
| $1.51M | 0.03% |
+150,000
| New | +$1.5M |
2026 Q2
0 quarters
|
|
235
Range Capital Acquisition Corp II
RNGT
$320M
| $1.51M | 0.03% |
150,000
| – | – |
2025 Q4
2 quarters
|
|
236
Long Table Growth Corp Units
LTGRU
| $1.5M | 0.03% |
+150,000
| New | +$1.5M |
2026 Q2
0 quarters
|
|
|
ISNRU
237
Snow Rothschild Acquisition Corp Units
ISNRU
| $1.5M | 0.03% |
+150,000
| New | +$1.5M |
2026 Q2
0 quarters
|
|
238
Proem Acquisition Corp I
PAAC
| $1.49M | 0.03% |
+150,000
| New | +$1.49M |
2026 Q2
0 quarters
|
|
239
Abony Acquisition Corp I
AACO
$313M
| $1.49M | 0.03% |
+150,000
| New | +$1.48M |
2026 Q2
0 quarters
|
|
240
Hemab Therapeutics
COAG
$1.39B
| $1.47M | 0.03% |
+40,000
| New | +$1.1M |
2026 Q2
0 quarters
|
|
241
Heartflow Inc
HTFL
$4.32B
| $1.47M | 0.03% |
50,000
| – | – |
2025 Q3
3 quarters
|
|
242
Aeva Technologies
AEVA
$791M
| $1.44M | 0.03% |
+50,000
| New | +$984K |
2026 Q2
0 quarters
|
|
|
FRBT
243
Forbright Inc
FRBT
$867M
| $1.37M | 0.03% |
+75,000
| New | +$1.36M |
2026 Q2
0 quarters
|
|
244
Wealthfront Corp
WLTH
$1.61B
| $1.34M | 0.03% |
150,000
-200,000
| -57% | -$2.08M |
2025 Q4
2 quarters
|
|
245
Apogee Acquisition Corp
AACP
| $1.24M | 0.02% |
+125,000
| New | +$1.25M |
2026 Q2
0 quarters
|
|
246
Veradermics Inc
MANE
$4.83B
| $1.23M | 0.02% |
10,000
+5,000
| +100% | +$468K |
2026 Q1
1 quarter
|
|
247
Sinda Ltd
SIND
$2.12B
| $1.2M | 0.02% |
+100,000
| New | +$1.2M |
2026 Q2
0 quarters
|
|
|
KARD
248
Kardigan Inc
KARD
$1.17B
| $1.19M | 0.02% |
+50,000
| New | +$1.16M |
2026 Q2
0 quarters
|
|
249
Bullish
BLSH
$4.83B
| $1.17M | 0.02% |
50,000
-60,000
| -55% | -$2.09M |
2025 Q3
3 quarters
|
|
250
PicS N.V.
PICS
$1.7B
| $1.12M | 0.02% |
105,000
-120,000
| -53% | -$1.36M |
2026 Q1
1 quarter
|
|
Similar funds
KACA
MRCP
CFO
YCM
BPCE
GIBU
ACM
BMO
Ghisallo Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Ghisallo Capital Management held 458 positions worth $5.1B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Ghisallo Capital Management deployed $410M of net new capital in Q2 2026, opening 148 new positions and adding to 12 existing holdings. Its largest new stake was SpaceX: 5,678,145 shares worth $970M.
By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Communication Services.
On the sell side, the largest reduction was Medline Inc, an estimated $62.3M trimmed.
- Ghisallo Capital Management's largest Q2 2026 buy was SpaceX: 5,678,145 shares worth $970M.
- Ghisallo Capital Management added most to Diamondback Energy in Q2 2026, an estimated $29.1M increase.
- Ghisallo Capital Management's biggest Q2 2026 reduction was Medline Inc, cutting an estimated $62.3M.
- Ghisallo Capital Management fully exited Tesla in Q2 2026, selling an estimated $102M.
- Ghisallo Capital Management's ten largest holdings make up 43% of its $5.1B portfolio in Q2 2026.
- Ghisallo Capital Management opened 148 new positions and closed 123 in Q2 2026.
- Ghisallo Capital Management's portfolio value rose 40% quarter-over-quarter to $5.1B.
Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.